Home / Pharmaceuticals / Veterinary Biologics Market By Product (Vaccines, Diagnostic Kits, Nutritional and Hormonal Supplement, Allergenic Extract and Others), By Type (Production Animal and Companion Animal) - Growth, Future Prospects & Competitive Analysis, 2018 - 2026

Veterinary Biologics Market By Product (Vaccines, Diagnostic Kits, Nutritional and Hormonal Supplement, Allergenic Extract and Others), By Type (Production Animal and Companion Animal) - Growth, Future Prospects & Competitive Analysis, 2018 - 2026

Published: Jan 2019 | Report Code: 59540-01-19

The veterinary biologics market is set to reach from US$ 17,704.7 Mn in 2017 to US$ 29,706.9 Mn by 2026 at a compound annual growth rate (CAGR) of 6.0% during the forecast period from 2018 to 2026. Veterinary biologics are medicinal products obtained from living organism and biological processes. They are employed in veterinary health science to diagnose, prevent and treat animal disease through immune-modulation. According to United States Department of Agriculture (USDA), over the span of 70 years there has been a significant growth in the veterinary biologics market, wherein today approximately 2000 licensed biological products are employed to treat 200 different types of disease in 35 animal species.

Market Synopsis

Veterinary Biologics Market 

Rising prevalence of zoonotic diseases and technological development in vaccine production by recombinant DNA technology drive the vaccines market growth.

Vaccines are currently leading the product segment for veterinary biologics market. The major factors contributing to its culminating growth are rising prevalence of zoonotic disease and technological innovation in veterinary vaccines production employing the recombinant DNA technology. Molecular diagnostic kits holds the second largest market in the products segment on account of increasing prevalence of contagious disease in poultry, bovine and porcine animal species. Nutritional and hormonal supplement will be the fastest growing market on account of increasing demand for dairy and meat industry and growing important of probiotics to improve animal feed products quality.

Veterinary Biologics Market 

Proactive government policies focusing on long term sustainable development and improving livestock health drive the production animal market growth

Currently production animals are reigning the animal type segment pertaining to veterinary biologics market. Proactive government policies throughout the globe are focusing on long term sustainable growth by ensuring total food security and improving livestock healthcare. According to the research findings of Food and Agriculture Organization (FAO), animal based food products accounts for one third of human protein consumption. Rampant growth in dairy industry further propels the production animal market growth. Companion animals will be the fastest growing animal type segment in the near future due to significant growth in pet adoption and stringent government norms for mandatory vaccination of pet animals.

Veterinary Biologics Market 

Existence of highly developed agrobased industry and rampant growth in animal husbandry department drive the market growth in North America

In the present scenario North America accounts for 40% of the global market share in veterinary biologics market. The key factors responsible for the dominance of North America are presence of highly developed agrobased industry and rapid growth in animal husbandry department. Rising public animal health awareness and significant growth in pet adoption further fortify the veterinary biologics market growth in North America. Europe represents 31% market share and is the second largest regional segment for veterinary biologics market. Increasing growth in dairy and meat industry and stringent regulatory norms imposed by healthcare agencies for compulsory vaccination of animals propels the market growth in European region. Asia Pacific holds 17% market share and will be the fastest growing market during the forecast period from 2018 to 2026. Rising prevalence of zoonotic disease and proactive government policies to financially support veterinary departments consolidate the veterinary biologics market growth in Asia Pacific region. Latin America and Middle East & Africa serve as a potential market for major players to promote business expansion and capture the untapped market in rural areas.

Veterinary Biologics Market

Historical & Forecast Period

2016 – Historical Year

2017 – Base Year

2018-2026 – Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Veterinary Biologics Market 

Report Scope by Segments

The market segmentation comprises of by product, type and geography.

By Product (2016–2026; US$ Mn)

  • Vaccines
  • Diagnostic Kits
  • Nutritional and Hormonal Supplement
  • Allergenic Extract
  • Others

By Type (2016–2026; US$ Mn)

  • Production Animal
  • Companion Animal

Geography Segment (2016–2026; US$ Mn)

  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • GCC
    • Rest of MEA

Biopharmaceutical companies actively participating in veterinary biologics market are Boehringer Ingelheim Animal Health GmbH, Ceva Sante Animale, Evonik Industries AG, Heska Corporation, Intervet, Inc., INDICAL Bioscience, IDEXX Laboratories, Inc., Virbac, Inc., VCA, Inc. and Zoetis.

Key questions answered in this report

  • Who are the major biopharmaceutical companies actively participating in veterinary biologics market?
  • How is the market assessment performed and what are the latest market trends prevalent in veterinary biologics market?
  • What are veterinary biologics and how do they impact animal health?
  • What will be the market size and CAGR for veterinary vaccines market during the forecast period 2018 to 2026?
  • What factors are responsible for the dominance of companion animal market growth?
  • What will be the performance of Asia Pacific region in the near future?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Veterinary Biologics Market Portraiture
2.2. Global Veterinary Biologics Market, by Product, 2017 (US$ Mn)
2.3. Global Veterinary Biologics Market, by Type, 2017 (US$ Mn)
2.4. Global Veterinary Biologics Market, by Geography, 2017 (US$ Mn)

Chapter 3. Veterinary Biologics Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Veterinary Biologics Market, by Key Players, 2017

Chapter 4. Global Veterinary Biologics Market, by Product
4.1. Overview
4.2. Vaccines
4.3. Diagnostic Kits
4.4. Nutritional and Hormonal Supplement
4.5. Allergenic Extract
4.6. Others

Chapter 5. Global Veterinary Biologics Market, by Type
5.1. Overview
5.2. Production Animal
5.3. Companion Animal

Chapter 6. Global Veterinary Biologics Market, by Geography
6.1. Overview
6.2. North America Veterinary Biologics Market Analysis, 2016 – 2026
6.2.1. North America Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
6.2.2. North America Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
6.2.3. North America Veterinary Biologics Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Veterinary Biologics Market Analysis, 2016 – 2026
6.3.1. Europe Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
6.3.2. Europe Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
6.3.3. Europe Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Veterinary Biologics Market Analysis, 2016 – 2026
6.4.1. Asia Pacific Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America Veterinary Biologics Market Analysis, 2016 – 2026
6.5.1. Latin America Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
6.5.2. Latin America Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
6.5.3. Latin America Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa Veterinary Biologics Market Analysis, 2016 – 2026
6.6.1. MEA Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
6.6.2. MEA Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
6.6.3. MEA Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Boehringer Ingelheim Animal Health GmbH
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Ceva Sante Animale
7.3. Evonik Industries AG
7.4. Heska Corporation
7.5. Intetvet, Inc.
7.6. INDICAL Bioscience
7.7. IDEXX Laboratories, Inc.
7.8. Virbac, Inc.
7.9. VCA, Inc.
7.10. Zoetis

FIG. 1 Veterinary Biologics Market: Research Methodology
FIG. 2 Veterinary Biologics: Market Segmentation
FIG. 3 Global Veterinary Biologics Market, by Product, 2017 (US$ Mn)
FIG. 4 Global Veterinary Biologics Market, by Type, 2017 (US$ Mn)
FIG. 5 Global Veterinary Biologics Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global Veterinary Biologics Market, by Key Players, 2017
FIG. 8 Global Vaccines Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 9 Global Diagnostic Kits Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 10 Global Nutritional and Hormonal Supplements Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 11 Global Allergenic Extracts Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 12 Global Other Products Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 13 Global Production Animals Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 14 Global Companion Animals Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 15 U.S. Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 16 Canada Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 17 U.K. Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 18 Germany Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 19 Rest of Europe Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 20 China Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 21 Japan Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Asia Pacific Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 23 Brazil Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 24 Mexico Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Latin America Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 26 GCC Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 27 Rest of MEA Veterinary Biologics Market, 2016 – 2026 (US$ Mn)

TABLE 1 Global Veterinary Biologics Market Portraiture
TABLE 2 Global Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global Veterinary Biologics Market , by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Veterinary Biologics Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 6 North America Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America Veterinary Biologics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Boehringer Ingelheim Animal Health GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Ceva Sante Animale: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Evonik Industries AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Heska Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Intervet, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 INDICAL Bioscience.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 IDEXX Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Virbac, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 VCA, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Zoetis: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients